Your search returned 2 results.

Results
	1.	Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma. [electronic resource] by Even, C Lassen, U Merchan, J Le Tourneau, C Soria, J-C Ferte, C Ricci, F Diener, J T Yuen, E Smith, C Oakley, G J Benhadji, K A Massard, Christophe Producer: 20210303 In: Investigational new drugs vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours. [electronic resource] by Mir, Olivier Azaro, Analia Merchan, Jaime Chugh, Rashmi Trent, Jonathan Rodon, Jordi Ohnmacht, Ute Diener, J T Smith, Claire Yuen, Eunice Oakley, Gerard Joseph Le Cesne, Axel Soria, Jean-Charles Benhadji, Karim A Massard, Christophe Producer: 20190520 In: European journal of cancer (Oxford, England : 1990) vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search